GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
135 hedge funds and large institutions have $1.09B invested in Genomic Health, Inc. in 2017 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
5% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 20
1% more funds holding
Funds holding: 134 → 135 (+1)
Holders
135
Holding in Top 10
3
Calls
$3.22M
Puts
$202K
Top Buyers
| 1 | +$15.3M | |
| 2 | +$5.26M | |
| 3 | +$4.83M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.46M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$3.06M |
Top Sellers
| 1 | -$8.52M | |
| 2 | -$5.2M | |
| 3 | -$2.02M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$1.82M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.65M |